| AGEs | Advanced Glycation End-products |
| a-SMA | a-Smooth Muscle Actin |
| AZA | Azathioprine |
| CNIs | Calcineurin Inhibitors |
| EMT | Epithelial-to-Mesenchymal Transition |
| eNOS | endothelial Nitric Oxide Synthase |
| EPS | Encapsulating Peritoneal Sclerosis |
| ESRD | End Stage Renal Disease |
| H2 | Dissolved Molecular Hydrogen |
| HD | Hemodialysis |
| MCP-1 | Monocyte Chemoattractant Protein-1 |
| MCs | Mesothelial Cells |
| MMF | Mycophenolate Mofetil |
| MMP9 | Matrix MetalloProteinase-9 |
| MMT | Mesothelial-to-Mesenchymal Transition |
| mTOR | Mammalian Target of Rapamycin |
| NAC | N-Acetylcysteine |
| PD | Peritoneal Dialysis |
| PM | Peritoneal Membrane |
| PPAR | Peroxisome Proliferator-Activated Receptor |
| PTX | Pentoxifylline |
| RAAS | Renin–Angiotensin–Aldosterone System |
| TGF-β1 | Transforming Growth Factor–β1 |
| UF | UltraFiltration |
| UFF | UltraFiltration Failure |
| VEGF | Vascular Endothelial Growth Factor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.